AVE 16.7% 0.3¢ avecho biotechnology limited

deadlier than cocaine and heroine., page-14

  1. 10,009 Posts.
    Oscar, Of course I am excited. Lately the thread has gone sour on the management of the coy. But stand back a have a good look. A previous post highlighted a 2008 remark regarding how hard it was to set a deal.

    Its now 2010 and Oxycodone has moved down the track a fair distance from 2008. Most investors have been reading company hype about the technology for some time. All exciting but not much ever eventuating. It has been explained to me that all this time POH was still developing and improving it until we have it at the stage it is quite robust and ready to sell.

    The early announcements and newsletters from POH got excited prematurely. At this point in time they really do have a product that is saleable. See Gmuttons post on just one opportunity (fat burner).

    This should be a good year for progress. Hopefully on both fronts commercially and managerially.

    PoS

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $3.226K 1.116M

Buyers (Bids)

No. Vol. Price($)
52 92468918 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 76402411 25
View Market Depth
Last trade - 12.50pm 06/09/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.